Skip to content
PeptideAgent

Telehealth providers in Maryland

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in Maryland, including asynchronous care. What Maryland requires of telehealth prescribers and pharmacies, plus verified listings.

Maryland at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving Maryland

No verified telehealth providers serving Maryland are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in Maryland

The Preserve Telehealth Access Act of 2021 added Health Occupations Article sections 1-1001 through 1-1006. Telehealth is defined to include both synchronous and asynchronous interactions, and an asynchronous interaction includes the secure transmission of medical information, clinical data, images, lab results, and self-reported medical history. Section 1-1003 requires a clinical evaluation before a practitioner provides telehealth services and states that the practitioner may use a synchronous or an asynchronous telehealth interaction to perform it; telehealth care is held to the same standard as in-person care. The stricter in-person assessment requirement in section 1-1003 applies only to certain controlled substances, such as Schedule II opioids. The Maryland Board of Physicians implements these rules for physicians in COMAR 10.32.05. The practitioner must be licensed in Maryland. Semaglutide, tirzepatide, and the other peptides in this database are not controlled substances, so federal telemedicine controlled substance rules do not apply. [2] [3] [4]

Compounded GLP-1 access in Maryland

Maryland's asynchronous telehealth rule makes app-based GLP-1 programs lawful on the prescribing side, but the dispensing pharmacy must still hold a Maryland pharmacy or nonresident pharmacy permit. [3] [5] [11]

Research use only sellers in Maryland

Maryland's Food, Drug, and Cosmetic Act (Health-General Article, Title 21) prohibits selling adulterated or misbranded drugs, and Health Occupations Title 12 limits dispensing of prescription drugs to permitted pharmacies and authorized practitioners. [1] [9] [12]

How to check a telehealth provider in Maryland

  1. Confirm the prescriber is licensed or registered to treat patients located in Maryland; the telehealth rules above explain what Maryland requires. [2] [3] [4]
  2. Ask which pharmacy will fill the prescription and check it in the Maryland Board of Pharmacy (Maryland Department of Health) license lookup. [1] [5] [6] [7] [8] [10]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Maryland. [1] [9] [12]

Common questions in Maryland

Can I get a GLP-1 prescription in Maryland from an online questionnaire or app?

Maryland law allows it in principle. Health Occupations section 1-1003 lets a Maryland-licensed practitioner perform the required clinical evaluation through an asynchronous telehealth interaction, and the care must meet the in-person standard. The prescriber still decides whether the information is enough to prescribe safely. [2] [3]

Does a telehealth prescriber need a Maryland license?

Yes. Maryland's telehealth statute applies to practitioners licensed in Maryland, and the Board of Physicians' telehealth regulations in COMAR 10.32.05 require Maryland licensure to treat a patient located in Maryland. [2] [4]

Can an out-of-state pharmacy ship compounded peptides to me in Maryland?

Only if it holds a Maryland nonresident pharmacy permit. Under Health Occupations section 12-403, the pharmacy must submit its latest home-state inspection report and name a Maryland agent for service of process, and a pharmacy that ships compounded sterile preparations such as injectable peptides must also file a USP chapter 797 inspection report from an inspection done within 90 days before its application. Search the Board of Pharmacy license verification before ordering. [1] [5]

All peptide legal questions for Maryland

Sources

  1. [1]Maryland Board of Pharmacy
  2. [2]Maryland Code, Health Occupations section 1-1001, Telehealth definitions
  3. [3]Maryland Code, Health Occupations section 1-1003, Telehealth clinical evaluation and prescribing
  4. [4]COMAR 10.32.05, Telehealth (Maryland Board of Physicians)
  5. [5]Maryland Code, Health Occupations section 12-403, Required standards (including nonresident pharmacies)
  6. [6]COMAR Title 10, Subtitle 34, Board of Pharmacy regulations
  7. [7]COMAR 10.34.37.04, Requirements for nonresident pharmacy operations
  8. [8]Maryland Senate Bill 69 (2015), Chapter 5: repeal of the sterile compounding permit requirement
  9. [9]Maryland Code, Health-General Title 21, Food, Drugs, and Cosmetics
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  11. [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  12. [12]21 U.S.C. 331, Prohibited acts